APSARD

Check out these APSARD 2024 updates from Greg Mattingly, MD, president of the American Professional Society for ADHD and Related Disorders.

This APSARD 2024 conference poster finds that individuals with ADHD have distinct motivations and patterns of substance use.

The results were shared in a poster presentation at the 2024 APSARD Annual Meeting.

APSARD tackles the first US adult ADHD treatment guidelines.

Ann Childress, MD, the current president of APSARD, invites you to attend this year's conference!

In an exclusive interview, APSARD President Elect Greg Mattingly, MD, tells Psychiatric Times readers what they can expect at this year's meeting.

How do children with ADHD respond differently to reward and punishment, and how can we help them improve their executive functions?

What are the connections between ADHD, infectious diseases, and COVID-19?

How are minority children with ADHD affected by diagnostic, treatment, and educational inequities—and what can we do about it?

How does an ADHD diagnosis affect the college experience? Recent research allows the students to weigh in.

Is ADHD underdiagnosed or overdiagnosed? One doctor emphatically says the former.

You cannot touch mental health impairments, so how best can we measure them? Adaptive testing may be the answer.

College students who identify as a sexual and gender minority who also have ADHD may be at higher risk of functional impairments, substance use, and psychiatric comorbidities.

Helicopter parenting in teens with ADHD: What are the types and how do they affect children?

Ann Childress, MD, shares insights into ADHD in very young children at the 2022 APSARD Conference.